Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial

Rationale Idiopathic pulmonary fibrosis (IPF) has a dismal prognosis. Mesenchymal stromal cells (MSCs) have shown benefit in other inflammatory diseases. Objectives To evaluate the safety and feasibility of endobronchial administration of bone marrow autologous MSCs (BM-MSC) in patients with mild-to...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Arantza Campo, José María González-Ruiz, Enrique Andreu, Ana B. Alcaide, María M. Ocón, Juan De-Torres, Jesús Pueyo, Rosa Cordovilla, Eva Villaron, Fermín Sanchez-Guijo, Miguel Barrueco, Jorge Nuñez-Córdoba, Felipe Prósper, Javier J. Zulueta
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	European Respiratory Society 2021-06-01
Serie:	ERJ Open Research
Accesso online:	http://openres.ersjournals.com/content/7/2/00773-2020.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!